TGNA
37
-3
WU
36
2
EQIX
60
3
MAS
59
3
PM
66
6
L
51
5
LEN
53
3
NTRS
54
4
FRT
41
5
STI
28
9
MLM
58
-2
IVZ
52
6
NTAP
54
2
GE
61
4
MU
39
5
PEP
47
2
BAX
41
3
R
67
4
THC
67
2
NWS
62
4
TGNA
37
-3
WU
36
2
EQIX
60
3
MAS
59
3
PM
66
6
L
51
5
LEN
53
3
NTRS
54
4
FRT
41
5
STI
28
9
MLM
58
-2
IVZ
52
6
NTAP
54
2
GE
61
4
MU
39
5
PEP
47
2
BAX
41
3
R
67
4
THC
67
2
NWS
62
4
Financhill
Back

Apellis Pharmaceuticals Stock Predictions

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
42

APLS
Apellis Pharmaceuticals

Last Price:
29.07
Seasonality Move:
22.1%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Apellis Pharmaceuticals Stock Forecast

  • Over the next 52 weeks, Apellis Pharmaceuticals has on average historically risen by 19.9% based on the past 6 years of stock performance.
  • Apellis Pharmaceuticals has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Apellis Pharmaceuticals Stock Undervalued?
    The current Apellis Pharmaceuticals [APLS] share price is $28.08. The Score for APLS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Apellis Pharmaceuticals Stock Go Up Next Year?

  • Over the next 52 weeks, Apellis Pharmaceuticals has on average historically risen by 19.9% based on the past 6 years of stock performance.

Apellis Pharmaceuticals Stock Rating

Sell
42
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals overpriced?

  • Apellis Pharmaceuticals has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Apellis Pharmaceuticals Stock Price History

Is APLS stock going to rise?

  • The current trend is relatively stagnant and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
apellis.com

52-Week Data

52-Week High:
73.80
52-Week Low:
24.34

Prediction Charts

Market Cap:
3.42B
Price in USD:
28.08
Volume:
9.86M
Beta:
0.84

Technical Analysis

SMA50:
31.83
SMA100:
35.01
SMA200:
44.76
52-Wk Change:
-40.05%

Stock Predictions

  • Is Apellis Pharmaceuticals stock public?
    Yes, Apellis Pharmaceuticals is a publicly traded company.
  • What is the Apellis Pharmaceuticals stock quote today?
    The Apellis Pharmaceuticals stock price is 28.08 USD today.
  • How to buy Apellis Pharmaceuticals stock online?
    You can buy Apellis Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-16 28.25 27.95 28.62 27.35
Oct-18 27.90 28.00 28.34 27.75
Oct-21 27.93 26.88 28.00 26.53
Oct-22 26.62 27.60 28.12 26.48
Oct-23 27.60 26.98 27.65 26.77
Oct-24 26.82 27.58 28.22 26.80
Oct-25 27.18 26.68 27.80 26.67
Oct-28 27.50 27.34 27.80 26.67
Oct-29 27.42 27.41 28.09 26.95
Oct-30 26.86 27.71 28.06 26.80
Oct-31 27.55 27.25 28.17 27.21
Nov-1 27.31 27.98 28.11 27.11
Nov-4 27.58 28.52 30.13 27.47
Nov-5 25.40 28.08 28.33 24.34

Apellis Pharmaceuticals Earnings

Apellis Pharmaceuticals Earnings Report: Per Share Apellis Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Apellis Pharmaceuticals Forecast Revenue Growth

Apellis Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Apellis Pharmaceuticals and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.29 per share, and an increase next year of $1.33 per share.

* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.